Literature DB >> 27082451

Growth hormone and ocular dysfunction: Endocrine, paracrine or autocrine etiologies?

Steve Harvey1, Carlos G Martinez-Moreno2.   

Abstract

The eye is a target site for GH action and growth hormone has been implicated in diabetic retinopathy and other ocular dysfunctions. However, while this could reflect the hypersecretion of pituitary GH, the expression of the GH gene is now known to occur in ocular tissues and it could thus also reflect excess GH production within the eye itself. The possibility that ocular dysfunctions might arise from endocrine, autocrine or paracrine etiologies of GH overexpression is therefore the focus of this brief review.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autocrine; Endocrine; Glaucoma; Growth hormone; Insulin-like growth factor-1; Paracrine; Retinopathy

Mesh:

Substances:

Year:  2016        PMID: 27082451     DOI: 10.1016/j.ghir.2016.03.004

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  6 in total

1.  Protective effects of agonists of growth hormone-releasing hormone (GHRH) in early experimental diabetic retinopathy.

Authors:  Menaka C Thounaojam; Folami L Powell; Sagar Patel; Diana R Gutsaeva; Amany Tawfik; Sylvia B Smith; Julian Nussbaum; Norman L Block; Pamela M Martin; Andrew V Schally; Manuela Bartoli
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-27       Impact factor: 12.779

Review 2.  Targeting growth hormone function: strategies and therapeutic applications.

Authors:  Man Lu; Jack U Flanagan; Ries J Langley; Michael P Hay; Jo K Perry
Journal:  Signal Transduct Target Ther       Date:  2019-02-08

Review 3.  Human Amniotic Mesenchymal Stem Cells Promote Endogenous Bone Regeneration.

Authors:  Jin Li; Zhixuan Zhou; Jin Wen; Fei Jiang; Yang Xia
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-02       Impact factor: 5.555

4.  Quantitative measures of the vascular and neural components of the retina in adult individuals with congenital and untreated growth hormone deficiency.

Authors:  Nelmo V Menezes; Cynthia S Barros-Oliveira; Roberto Salvatori; Vinicius C Gois; Cindi G Marinho; Carla R P Oliveira; Viviane C Campos; Alécia A Oliveira-Santos; Hertz T Santos-Júnior; Elenilde G Santos; Enaldo V Melo; Augusto C N Faro; Neima V Oliveira; Hérika M Gumes-Felix; Gustavo B Melo; Manuel H Aguiar-Oliveira
Journal:  Int J Retina Vitreous       Date:  2022-10-01

Review 5.  Growth Hormone (GH) and Gonadotropin-Releasing Hormone (GnRH) in the Central Nervous System: A Potential Neurological Combinatory Therapy?

Authors:  Carlos G Martínez-Moreno; Denisse Calderón-Vallejo; Steve Harvey; Carlos Arámburo; José Luis Quintanar
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

6.  Evaluation of Peripapillary Microcirculation in Patients with Acromegaly.

Authors:  Mine Karahan; Atilim Armagan Demirtas; Leyla Hazar; Sedat Ava; Zafer Pekkolay; Ugur Keklikci
Journal:  Beyoglu Eye J       Date:  2021-12-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.